Establishment Net Receivables from 2010 to 2026
| ESTA Stock | USD 73.54 0.82 1.13% |
Net Receivables | First Reported 2016-12-31 | Previous Quarter 70.1 M | Current Value 71.4 M | Quarterly Volatility 19.2 M |
Check Establishment Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Establishment Labs' main balance sheet or income statement drivers, such as Interest Income of 1.8 M, Interest Expense of 25.2 M or Selling General Administrative of 82 M, as well as many indicators such as Price To Sales Ratio of 11.34, Dividend Yield of 0.0 or PTB Ratio of 23.09. Establishment financial statements analysis is a perfect complement when working with Establishment Labs Valuation or Volatility modules.
Establishment | Net Receivables | Build AI portfolio with Establishment Stock |
Analyzing Establishment Labs's Net Receivables over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Receivables has evolved provides context for assessing Establishment Labs's current valuation and future prospects.
Latest Establishment Labs' Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Establishment Labs Holdings over the last few years. It is Establishment Labs' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Establishment Labs' overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Establishment Net Receivables Regression Statistics
| Arithmetic Mean | 26,129,895 | |
| Geometric Mean | 17,079,458 | |
| Coefficient Of Variation | 96.14 | |
| Mean Deviation | 19,992,440 | |
| Median | 17,648,000 | |
| Standard Deviation | 25,120,702 | |
| Sample Variance | 631T | |
| Range | 71.8M | |
| R-Value | 0.89 | |
| Mean Square Error | 140.2T | |
| R-Squared | 0.79 | |
| Slope | 4,426,528 | |
| Total Sum of Squares | 10096.8T |
Establishment Net Receivables History
About Establishment Labs Financial Statements
Establishment Labs stakeholders use historical fundamental indicators, such as Establishment Labs' Net Receivables, to determine how well the company is positioned to perform in the future. Although Establishment Labs investors may analyze each financial statement separately, they are all interrelated. For example, changes in Establishment Labs' assets and liabilities are reflected in the revenues and expenses on Establishment Labs' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Establishment Labs Holdings. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 74.8 M | 78.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Establishment Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Establishment Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Establishment Labs Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Establishment Labs Holdings Stock:Check out the analysis of Establishment Labs Correlation against competitors. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. Projected growth potential of Establishment fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Establishment Labs assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (2.84) | Revenue Per Share | Quarterly Revenue Growth 0.337 | Return On Assets | Return On Equity |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Establishment Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Establishment Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Establishment Labs' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.